Form 4: Humana Executive John-Paul W. Felter Reports Stock Transactions
SEC Form 4 Filing
Humana's SVP, Chief Accounting Officer & Controller, John-Paul W. Felter, reported the vesting and subsequent sale of shares to cover tax liabilities related to restricted stock units.
Summary
- John-Paul W. Felter, SVP, Chief Accounting Officer & Controller at Humana Inc., filed a Form 4 detailing stock transactions.
- On December 15, 2024, Mr. Felter had 114 restricted stock units vest, which converted into 114 shares of Humana common stock.
- He then disposed of 83 shares of Humana common stock at a price of $271.675 per share to cover tax liabilities associated with the vesting of the restricted stock units.
- The transactions were related to restricted stock units granted on August 1, 2022, and February 24, 2023, which vest in tranches.
- Following these transactions, Mr. Felter directly owns 891 shares of Humana common stock.
Sentiment
Score: 5
Explanation: The document is a routine filing of stock transactions by an executive, which is neither positive nor negative for the company's performance.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It provides transparency into the stock transactions of company insiders.
Comparison to Industry Standards
- The vesting schedule of the restricted stock units, with 33% vesting annually over three years, is a common practice in executive compensation packages.
- The sale of shares to cover tax liabilities is also a standard procedure for executives receiving stock-based compensation.
- Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also have similar reporting requirements for their executives' stock transactions.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are related to executive compensation and do not indicate a change in the company's fundamentals.
Key Dates
| Date | Description |
|---|---|
| 08/01/2022 | Date of grant for some of the restricted stock units, vesting in three tranches. |
| 02/24/2023 | Date of grant for some of the restricted stock units, vesting in three tranches. |
| 12/15/2024 | Date of the reported transactions, including vesting of restricted stock units and sale of shares for tax purposes. |
| 12/17/2024 | Date the Form 4 was signed. |
Keywords
Form 4, Humana, Stock Transactions, Restricted Stock Units, Insider Trading, Executive Compensation, Share Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.